Literature DB >> 16945214

Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment.

Paola Forti1, Fabiola Maioli, Nicoletta Pisacane, Elisa Rietti, Fausta Montesi, G Ravaglia.   

Abstract

OBJECTIVES: Mild cognitive impairment (MCI) is regarded as a precursor to dementia, but not all patients with MCI actually develop dementia. As Alzheimer and vascular dementia are thought to share many common etiopathogenetic mechanisms, we investigated whether the vascular risk factor atrial fibrillation affects the risk of conversion to dementia for different MCI subtypes diagnosed according to international criteria.
METHODS: One hundred and eighty elderly outpatients with MCI and 431 elderly outpatients with a normal cognition were followed up for a mean of 3 and 4 years, respectively. The risk of conversion to dementia associated with atrial fibrillation was studied in both samples using a Cox proportional hazards model adjusted for socio-demographic and medical variables.
RESULTS: Overall conversion rate to dementia was 10.5 (8.0-13.8 per 100 person-years) in the MCI group and 2.2 (1.5-3.1 per 100 person-years) in the normal cognition group. Atrial fibrillation was significantly associated with conversion to dementia [hazard ratio (HR): 4.63; 95% confidence interval: 1.72-12.46] in the MCI group but not in the cognitively normal group (HR: 1.10; 95% confidence interval: 0.40-3.03). DISCUSSION: Current diagnostic criteria for MCI subtypes define heterogeneous populations, but atrial fibrillation can be useful in identifying people with increased risk of conversion to dementia.

Entities:  

Mesh:

Year:  2006        PMID: 16945214     DOI: 10.1179/016164106X130461

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  16 in total

1.  Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian Appleby; Esther Oh; Jeannie-Marie Leoutsakos; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-15       Impact factor: 3.485

2.  APOE genotype modifies the association between central arterial stiffening and cognition in older adults.

Authors:  Francis E Cambronero; Dandan Liu; Jacquelyn E Neal; Elizabeth E Moore; Katherine A Gifford; James G Terry; Sangeeta Nair; Kimberly R Pechman; Katie E Osborn; Timothy J Hohman; Susan P Bell; J David Sweatt; Thomas J Wang; Joshua A Beckman; John Jeffrey Carr; Angela L Jefferson
Journal:  Neurobiol Aging       Date:  2018-02-20       Impact factor: 4.673

3.  Atrial fibrillation and risk of dementia: a prospective cohort study.

Authors:  Sascha Dublin; Melissa L Anderson; Sebastien J Haneuse; Susan R Heckbert; Paul K Crane; John C S Breitner; Wayne McCormick; James D Bowen; Linda Teri; Susan M McCurry; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2011-08-01       Impact factor: 5.562

4.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

Authors:  Irene Marzona; Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Jackie Bosch; Salim Yusuf
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

5.  Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort.

Authors:  Sascha Dublin; Melissa L Anderson; Susan R Heckbert; Rebecca A Hubbard; Joshua A Sonnen; Paul K Crane; Thomas J Montine; Eric B Larson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-09-28       Impact factor: 6.053

6.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

Review 7.  Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.

Authors:  Charlotte J Bai; Nidhi Madan; Shaza Alshahrani; Neelum T Aggarwal; Annabelle Santos Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

8.  Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Eric G Tangalos; Robert J Ivnik; Michelle M Mielke; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

9.  Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

Authors:  P B Rosenberg; M M Mielke; J Tschanz; L Cook; Chris Corcoran; K M Hayden; M Norton; P V Rabins; R C Green; K A Welsh-Bohmer; J C S Breitner; R Munger; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2008-11       Impact factor: 4.105

10.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.